BDBM350676 US10208071, Compound 138::US10434112, Compound 138::US10799518, Compound 138::diethyl ({[(2S)-4-methyl-2-({[4- (methylsulfanyl)phenyl]carbamoyl} amino)pentanoyl]amino} methyl)phosphonate

SMILES CCOP(=O)(CNC(=O)[C@H](CC(C)C)NC(=O)Nc1ccc(SC)cc1)OCC

InChI Key InChIKey=IZJUGUJPXFXTQE-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350676   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350676(diethyl ({[(2S)-4-methyl-2-({[4- (methylsulfanyl)p...)
Affinity DataEC50:  3.5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350676(diethyl ({[(2S)-4-methyl-2-({[4- (methylsulfanyl)p...)
Affinity DataEC50:  3.5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350676(diethyl ({[(2S)-4-methyl-2-({[4- (methylsulfanyl)p...)
Affinity DataEC50:  3.50E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent